Insmed INSM
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 0th percentile, 5-year average -12.7x
Above its usual level · 77th percentile, 5-year average 30.0x
#5265 of 5338 stocks by PB (1 = cheapest)
Around its usual level · 53rd percentile, 5-year average 29.4x
#4762 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 42.70 | – | 30.01 | 77% (pricier than usual) | #5265 of 5338 (1 = cheapest) |
| PE | -50.30 | -1,549.49 | -12.67 | 0% (cheaper than usual) | – |
| PS | 20.40 | 11.31 | 29.38 | 53% (pricier than usual) | #4762 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on INSM.
Sign in to join the discussion.